Ergoteles’s Monster Beverage MNST Stock Holding History

Ergoteles’s Portfolio MNST Stock Details MNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,486	Closed	-$685K	–	1575
2022 Q4	$685K	Buy	+13,486	New	+$653K	0.03%	590
2021 Q3	–	Sell	-4,624	Closed	-$211K	–	1507
2021 Q2	$211K	Buy	+4,624	New	+$217K	﹤0.01%	1244
2020 Q4	–	Sell	-34,400	Closed	-$1.38M	–	819
2020 Q3	$1.38M	Buy	+34,400	New	+$1.36M	0.18%	100

Other funds holding MNST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Ergoteles's MNST Position: Q1 2023 in Review

Ergoteles sold out of Monster Beverage (MNST) in Q1 2023, closing a stake of 13,486 shares — an estimated $685K sold.

Ergoteles first reported a position in MNST in Q3 2020 and held it in 3 quarters. The position peaked at $1.38M in Q3 2020. 855 funds tracked by Wall St. Rank hold MNST as of Q1 2023.

Ergoteles reported no remaining Monster Beverage position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 13,486 Monster Beverage shares in Q1 2023, an estimated $685K.
Ergoteles first reported a position in Monster Beverage in Q3 2020 and held it in 3 quarters.
Ergoteles's Monster Beverage position peaked at $1.38M in Q3 2020.
855 funds tracked by Wall St. Rank held Monster Beverage as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.